Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00242970 · ClinicalTrials.gov registry record
Hypertrophic Scarring After Facial Burn
A clinical trial, sponsored by Legacy Health System.
- Completed
- Registry status
- 15
- Enrollment target
NCT00242970: Completed study, sponsored by Legacy Health System.
NCT00242970 is a clinical trial that has completed, run by Legacy Health System. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00242970 has completed, sponsored by Legacy Health System.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.
Primary Outcome
Can a 3-D scanner measure static and dynamic changes
Interventions
- DEVICE 3-Dimensional Color Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-02 |
What the finished NCT00242970 record still lists
NCT00242970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 3-Dimensional Color Scanning is the first listed.
NCT00242970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00242970 about?
NCT00242970 is a clinical study titled "Hypertrophic Scarring After Facial Burn". Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.
What is the current status of trial NCT00242970?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2005-10. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00242970?
The interventions under investigation include: 3-Dimensional Color Scanning (DEVICE).
Who is sponsoring clinical trial NCT00242970?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia